Enterprise Value:
$4.26B+$110.11M(+2.65%)Summary
- As of today, PTGX enterprise value is $4.26 billion, with a rise of +$110.11 million (+2.65%) during the most recent trading session on October 17, 2025.
- Over the past year, PTGX enterprise value has increased by +$1.92 billion (+82.07%).
- PTGX enterprise value is now -12.18% below its all-time high of $4.85 billion.
Performance
PTGX Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
PTGX Enterprise Value Trends
| PeriodPeriod | Enterprise ValueEnterprise Value | Market CapMarket Cap | PricePrice |
|---|---|---|---|
| 1D1 Day | +2.6% | +2.3% | +2.3% |
| 1M1 Month | +36.4% | +30.9% | +30.9% |
| 3M3 Months | +44.7% | +37.5% | +37.3% |
| 6M6 Months | +85.1% | +68.2% | +67.5% |
| YTDYTD | +118.8% | +104.7% | +100.8% |
| 1Y1 Year | +82.1% | +72.3% | +64.8% |
| 5Y5 Years | +623.4% | +520.6% | +272.2% |
PTGX Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | $4.85B | -12.2% | $3.12B | +36.4% |
| 3M | 3-Month | $4.85B | -12.2% | $2.61B | +63.2% |
| 6M | 6-Month | $4.85B | -12.2% | $2.04B | +108.8% |
| 1Y | 1-Year | $4.85B | -12.2% | $1.75B | +144.1% |
| 3Y | 3-Year | $4.85B | -12.2% | $98.90M | +4209.6% |
| 5Y | 5-Year | $4.85B | -12.2% | $43.56M | +9684.5% |
| All-Time | All-Time | $4.85B | -12.2% | -$7.96M | >+9999.0% |
PTGX Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $4.26B(+118.8%) |
| 2024 | $1.95B(+98.2%) |
| 2023 | $982.78M(+222.7%) |
| 2022 | $304.59M(-76.8%) |
| 2021 | $1.32B(+125.9%) |
| Date | Value |
|---|---|
| 2020 | $582.05M(+667.2%) |
| 2019 | $75.87M(+179.1%) |
| 2018 | $27.19M(-90.8%) |
| 2017 | $294.63M(+1.6%) |
| 2016 | $290.11M |
FAQ
- What is Protagonist Therapeutics, Inc. enterprise value?
- What is the all-time high enterprise value for Protagonist Therapeutics, Inc.?
- What is PTGX enterprise value year-to-date change?
- What is Protagonist Therapeutics, Inc. enterprise value year-on-year change?
What is Protagonist Therapeutics, Inc. enterprise value?
The current enterprise value of PTGX is $4.26B
What is the all-time high enterprise value for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high enterprise value is $4.85B
What is PTGX enterprise value year-to-date change?
Protagonist Therapeutics, Inc. enterprise value has changed by +$2.31B (+118.81%) since the beginning of the year
What is Protagonist Therapeutics, Inc. enterprise value year-on-year change?
Over the past year, PTGX enterprise value has changed by +$1.92B (+82.07%)